Kokubunji, Japan

Hirotaka Kasai

This inventor holds 1 USPTO granted patent. Top assignees: Grelan Pharmaceutical Co., Ltd., Laboratoires Fournier S.c.a.. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hirotaka Kasai. Retrieved from https://idiyas.com/inventor/hirotaka-kasai

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hirotaka Kasai: Innovator in Pharmaceutical Chemistry

Introduction

Hirotaka Kasai is a notable inventor based in Kokubunji, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on 2-ureido-benzamide derivatives. His research has led to the development of a patent that showcases his expertise and creativity in this specialized area.

Latest Patents

Hirotaka Kasai holds 1 patent related to his work on 2-ureido-benzamide derivatives. This patent reflects his commitment to advancing pharmaceutical science and improving therapeutic options.

Career Highlights

Throughout his career, Kasai has worked with prominent companies in the pharmaceutical industry. He has been associated with Grelan Pharmaceutical Co., Ltd. and Laboratoires Fournier S.c.a., where he has contributed to various projects and innovations. His experience in these organizations has helped him refine his skills and expand his knowledge in drug development.

Collaborations

Kasai has collaborated with esteemed professionals in his field, including Jean Louis Binet and Christian Guffroy. These partnerships have allowed him to enhance his research and contribute to collective advancements in pharmaceutical chemistry.

Conclusion

Hirotaka Kasai is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable innovations. His patent on 2-ureido-benzamide derivatives exemplifies his dedication to improving healthcare solutions. His collaborations and career experiences further highlight his impact on the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…